Sign inJoin waitlistJoin the waitlist

James Brust

Professor, Department of Medicine · Montefiore Medical Center/Albert Einstein College of Medicine

Credentials: · · · · ·

History

Columbia Univ Coll of Phys & Surgeons
2007–2008
New York Presbyterian Hospital
2004–2007
Columbia University Medical Center
2001–2004
Columbia Univ Coll of Phys & Surgeons
1997–2001

Research

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Systematic review or meta-analysis · The Lancet · 2018 · 504 citations
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa
New England Journal of Medicine · 2017 · 211 citations
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
Systematic review or meta-analysis · The Lancet Respiratory Medicine · 2020 · 201 citations

NG
Neel Gandhi
41 papers
AC
Angela Campbell
11 papers
GF
Gerald Friedland
10 papers
SA
Sara Auld
10 papers · 1 as a fellow
NS
Neil Shah
8 papers
NS
Nishant Shah
8 papers
TB
Tyler Brown
8 papers · 6 as a fellow
Max O'Donnell
6 papers
Russell Kempker
6 papers
Henry Blumberg
4 papers
Jeffrey Collins
4 papers
Carol Benedict
3 papers · 1 as a fellow

Grants

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-Resistant Tuberculosis: A Pragmatic Randomized Controlled Trial
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.5M · Albert Einstein College of Medicine
2024–2029
Mentoring of Multidisciplinary Global Health Research in Tuberculosis and HIV
National Institute of Allergy and Infectious Diseases · K24
Contact PI · $889.2K · Albert Einstein College of Medicine
2020–2027
Emergence of Bedaquiline and Clofazimine Resistance After Interruption of Drug-Resistant TB Therapy in a High HIV Prevalence Setting
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.6M · Albert Einstein College of Medicine
2019–2026
Safety, Pharmacokinetics, and Resistance to Bedaquiline in XDR TB and HIV
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.7M · Albert Einstein College of Medicine
2015–2021

Clinical trials

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
Principal investigator · Recruiting
Albert Einstein College of Medicine
2026–2029